Pepijn A. Thomas

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.

Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.

Journal: Digestive diseases and sciences

Published: January 16, 2025

Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study.

Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study.

Journal: European journal of gastroenterology & hepatology

Published: January 28, 2023

Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective.

Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective.

Journal: Gastro hep advances

Published: October 30, 2022

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.

Journal: Digestive diseases and sciences

Published: September 16, 2022

Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.

Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis.

Journal: Inflammatory bowel diseases

Published: June 29, 2022

De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation.

De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation.

Journal: European journal of gastroenterology & hepatology

Published: January 02, 2022

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.

Journal: Inflammatory bowel diseases

Published: October 26, 2021

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.

Journal: Drug safety

Published: January 15, 2021

Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.

Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.

Journal: United European gastroenterology journal

Published: January 11, 2021

Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease.

Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease.

Journal: Scandinavian journal of gastroenterology

Published: December 10, 2020

Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.

Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.

Journal: Journal of Crohn's & colitis

Published: June 27, 2020

Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system.

Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system.

Journal: Pharmacoepidemiology and drug safety

Published: June 07, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026